Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc V.LXG


Primary Symbol: LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Post by TanzaniteMotherLodeon Aug 08, 2020 9:28pm
181 Views
Post# 31383679

Multi-billion $ markets to be disrupted by LXG

Multi-billion $ markets to be disrupted by LXG"Absolutely Lexagene could detect the Bubonic Plague. In fact unlike other rapid automated diagnostic devices that would take months to manufacture cartridges, Lexagene could detect a novel pathogens within days of sequencing. Lexagene’s unique open access ability allows custom assays to be utilized on MiQLab. This is a huge advantage for Lexagene and will allow Lexagene to target the multi $billion open access market. It will also be a game changer for future pandemics. Automated RT-PCR machines were not utilized until mid March and into April for most because of their closed access system. Lexagene could have been utilized within days of the Jan 11 sequencing of COVID-19. Once Governments discover and begin to understand how to prepare for containing future pandemics. Lexagene’s gold standard RT-PCR will standout as the obvious solution with the many advantages they have over existing solutions.Governments will be pouring money into pandemic preparedness in the next few years. You can guarantee the sales team will targeting this massive opportunity. Lexagene has so many multi $billion target markets they are preparing to disrupt"

From yahoo message board
<< Previous
Bullboard Posts
Next >>